The European Infrastructure for Translational Medicine (EATRIS) and the European Patients’ Academy on Therapeutic Innovation (EUPATI) have signed a partnership agreement, demonstrating both organisations’ commitment to provide education and training opportunities in translational research for patient advocates and strengthen academic researchers’ capacities to effectively engage with patients in their research. Supported by 13 EU Member…Read more
People at Risk for Serious Illness from COVID-19 CDC of the United States: If a COVID-19 outbreak happens in your community, it could last for a long time. (An outbreak is when a large number of people suddenly get sick.) Depending on how severe the outbreak is, public health officials may recommend community actions to…Read more
I participated in the second annual forum of the Scientific Panel for Health organised by the Directorate General for Research and Innovation of the European Union in Brussels on 9 June 2017. Held before a packed room of health research experts from around the EU, the title of the conference was “Health research in a…Read more
Following a long and intense application period, the selection committee for the EUPATI Patient Expert Training Course participants met on 9th May 2017 to decide who of the almost 170 applicants can participate in the course, which will start then in September 2017. Once again, the list of applicants was very impressive, which created an…Read more
Health Technology Assessment is gaining importance in regulatory decisions about the registration and reimbursement of health technologies in a growing number of European states. It is essential to involve patients in this process, and not only because the law requires such involvement in many countries, but also because evidence shows that patients who are informed…Read more
The key assets of EUPATI – the website, the Toolbox, and the Expert Training Course – will be maintained and developed, continuing to educate and empower patients for a more active role as partner in all aspects of medicines research and development.
National team activities on patient engagement in many European countries.
Commissie Tegemoetkoming Geneesmiddelen (CTG) | Бельгийский орган медицинско-технологической оценки
Компьютерная томография, КТ (CT — Computer Tomography)
Biomarkører er indikatorer, der bruges i medicinsk forskning til at måle biologiske processer, sygdomsprocesser og reaktioner på behandlinger. Brugen af biomarkører kan forbedre processen for udvikling af lægemidler og kan anvendes til at tilpasse behandlinger til enkeltpersoner.